Schedule 13D/A Filing for Fulgent Genetics, Inc.

This filing details changes in beneficial ownership of Fulgent Genetics, Inc. common stock by Ming Hsieh and The Ming Hsieh Trust. As of March 31, 2026, Ming Hsieh directly holds 8,867,303 shares, representing 30.74% ownership, with sole voting and dispositive power. The Ming Hsieh Trust holds 7,895,115 shares, representing 27.37% ownership, also under Ming Hsieh's sole control as trustee. Recent transactions include the vesting of equity awards and the termination of pre-paid forward arrangements. Ming Hsieh, also CEO and Chairperson of the Board, may adjust his holdings based on various factors. A portion of the Trust's shares are pledged as collateral for a credit facility and a pre-paid forward arrangement.